Literature DB >> 17055657

Cocaine-mediated supersensitivity of 5-HT2A receptors in hypothalamic paraventricular nucleus is a withdrawal-induced phenomenon.

G A Carrasco1, L D Van de Kar, N R Sullivan, M Landry, F Garcia, N A Muma, G Battaglia.   

Abstract

We previously reported that treatment and withdrawal from cocaine increases: (1) 5-HT2A receptor-mediated neuroendocrine responses, and (2) Galphaq and Galpha11 G-protein levels in the hypothalamic paraventricular nucleus (PVN) at 48 h post-treatment. This study investigates changes in the initial 24 h of withdrawal to discern whether 5-HT2A receptor supersensitivity is due to cocaine treatment or is induced during the withdrawal period. We report here increases in 5-HT2A receptor-mediated neuroendocrine responses only 12 or 24 h post-treatment, but not during the initial 4 h withdrawal period. Levels of membrane- or cytosol-associated Galphaq or Galpha11 proteins in PVN are not altered during the first 24 h of withdrawal. However, the density of 125I-(-)-1-(2,5 dimethoxy-4-iodophenyl)-2-amino-propane HCl (DOI)-labeled high-affinity 5-HT2A receptors in PVN increased 35% in rats withdrawn from cocaine for 24 h. These findings demonstrate that cocaine-induced increases in 5-HT2A receptor function in PVN represents a withdrawal-induced phenomena that: (1) is likely attributed to increased G-protein coupled/high-affinity conformational state of the 5-HT2A receptor, and (2) occurs in the absence of changes in the levels of associated G proteins during the first 24 h.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055657      PMCID: PMC1887047          DOI: 10.1016/j.neuroscience.2006.09.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  27 in total

Review 1.  Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.

Authors:  J A Gray; B L Roth
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

2.  Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.

Authors:  Yahong Zhang; Katerina J Damjanoska; Gonzalo A Carrasco; Bertalan Dudas; Deborah N D'Souza; Julie Tetzlaff; Francisca Garcia; Nicole R Sullivan Hanley; Kumar Scripathirathan; Brett R Petersen; Thackery S Gray; George Battaglia; Nancy A Muma; Louis D Van de Kar
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

3.  Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine(2A) receptor.

Authors:  Nicole R Sullivan Hanley; Julie G Hensler
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

4.  Psychological stress, drug-related cues and cocaine craving.

Authors:  R Sinha; T Fuse; L R Aubin; S S O'Malley
Journal:  Psychopharmacology (Berl)       Date:  2000-10       Impact factor: 4.530

Review 5.  Serotonin model of schizophrenia: emerging role of glutamate mechanisms.

Authors:  G K Aghajanian; G J Marek
Journal:  Brain Res Brain Res Rev       Date:  2000-03

6.  Effects of saline substitution on responding and plasma corticosterone in rats trained to self-administer different doses of cocaine.

Authors:  R L Peltier; G F Guerin; N Dorairaj; N E Goeders
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

7.  Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.

Authors:  Yan Zhou; Rudolph Spangler; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2003-02-28       Impact factor: 3.252

8.  Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use.

Authors:  J R Mantsch; V Yuferov; A-M Mathieu-Kia; A Ho; M J Kreek
Journal:  Psychoneuroendocrinology       Date:  2003-10       Impact factor: 4.905

Review 9.  Prolactin-releasing peptides.

Authors:  Willis K Samson; Meghan M Taylor; Jennifer R Baker
Journal:  Regul Pept       Date:  2003-06-15

Review 10.  Molecular biology of serotonin receptors structure and function at the molecular level.

Authors:  Wesley K Kroeze; Kurt Kristiansen; Bryan L Roth
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

View more
  9 in total

Review 1.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

Review 2.  Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Authors:  Leonard L Howell; Kathryn A Cunningham
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

3.  Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice.

Authors:  Yan Zhou; Rajani Maiya; Erin H Norris; Mary Jeanne Kreek; Sidney Strickland
Journal:  Stress       Date:  2010-07-28       Impact factor: 3.493

4.  Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.

Authors:  J M Franklin; T Vasiljevik; T E Prisinzano; G A Carrasco
Journal:  Eur Neuropsychopharmacol       Date:  2012-07-28       Impact factor: 4.600

5.  Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  Synapse       Date:  2012-12-08       Impact factor: 2.562

6.  Cocaine potentiates multiple 5-HT2A receptor signaling pathways and is associated with decreased phosphorylation of 5-HT2A receptors in vivo.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  J Mol Neurosci       Date:  2014-09-12       Impact factor: 3.444

7.  Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.

Authors:  Jade M Franklin; Matt Mathew; Gonzalo A Carrasco
Journal:  Neurosci Lett       Date:  2013-05-27       Impact factor: 3.046

8.  Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.

Authors:  Jade M Franklin; Tamara Vasiljevik; Thomas E Prisinzano; Gonzalo A Carrasco
Journal:  Pharmacol Res       Date:  2012-11-19       Impact factor: 7.658

9.  Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.

Authors:  B A Nic Dhonnchadha; R G Fox; S J Stutz; K C Rice; K A Cunningham
Journal:  Behav Neurosci       Date:  2009-04       Impact factor: 1.912

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.